Hi all,
Just to clarify where we are up to on keloid and hypertrophic scarring.
The Company has reformulated the product into SNT 9465 a next generation pan lox inhibitor.
Below is the last trial results which indicated a new version was required. I believe what Professor Wood says about the new version, it's a paradigm shift compared to SNT 6302. Trials to start soon.
https://www.medrxiv.org/content/10.1101/2025.02.12.25321764v1
Kpax
- Forums
- ASX - By Stock
- Value of Syntara
SNT
syntara limited
Add to My Watchlist
17.9%
!
5.5¢

Hi all,Just to clarify where we are up to on keloid and...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
5.5¢ |
Change
-0.012(17.9%) |
Mkt cap ! $89.35M |
Open | High | Low | Value | Volume |
6.7¢ | 6.7¢ | 5.5¢ | $557.8K | 9.456M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 8258 | 6.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.2¢ | 26672 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 108258 | 0.058 |
1 | 100000 | 0.057 |
2 | 30000 | 0.056 |
2 | 26681 | 0.055 |
2 | 225780 | 0.054 |
Price($) | Vol. | No. |
---|---|---|
0.052 | 26672 | 4 |
0.056 | 40000 | 1 |
0.057 | 489390 | 6 |
0.058 | 333256 | 3 |
0.059 | 50000 | 1 |
Last trade - 15.59pm 16/06/2025 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |